MA17338

Chlamydia LPS Monoclonal Antibody (B410F), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 MA17338-Each-of-1 In Stock ₹ 47,481.50

MA17338 - Each of 1

₹ 47,481.50

In Stock

Quantity

1

Base Price: ₹ 47,481.50

GST (18%): ₹ 8,546.67

Total Price: ₹ 56,028.17

Antigen

Chlamydia LPS

Classification

Monoclonal

Concentration

0.1 mg/mL

Formulation

PBS with 0.1% sodium azide; pH 7.2

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Target Species

Bacteria

Product Type

Antibody

Isotype

IgG1

Applications

ELISA, Immunohistochemistry

Clone

B410F

Conjugate

Unconjugated

Gene Alias

Chlamydia Lipopolysaccharide

Immunogen

Lipopolysaccharide.

Quantity

100 μg

Primary or Secondary

Primary

Content And Storage

4° C

Form

Liquid

Related Products

Img

Thermo Scientific

MA17303

--

Img

Thermo Scientific

MA17447

--

Img

Thermo Scientific

MA17339

--

Img

Thermo Scientific

MA17401

--

Img

Thermo Scientific

MA17029

--

Img

Thermo Scientific

MA17486

--

Img

Thermo Scientific

MA17402

--

Img

Thermo Scientific

MA17039

--

Description

  • The MA1-7338 antibody reacts with Chlamydia sp
  • LPS in bacterial and infected tissue samples
  • MA1-7338 has been successfully used in ELISA, Immunofluorescence and Immunohistochemical applications
  • The MA1-7338 antibody was raised against group-specific lipopolysaccharide
  • Chlamydia trachomatis is an intracellular organism
  • Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men
  • Chlamydial infections are believed to be one of the most common of all STDs
  • It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year
  • Thus, there are many undiagnosed cases of chlamydia in the community
  • It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5% to 10%
  • Chlamydia is one of the leading causes of blindness in underdeveloped countries.